Patent · US Active

Assessing left ventricular remodeling via temporal detection and measurement of microRNA in body fluids

US8592151B2 · kind B2 · utility

0Cited by

10References

19Claims

0Family size

Assignee

MUSC Foundation for Research Development · US

Inventors

Francis G. Spinale · Charleston, US
Michael R. Zile · Charleston, US
Robert E. Stroud · Fairfax, US

Key dates

Filing date	Nov 11, 2010
Grant date	Nov 26, 2013
Priority date	—
Expiry date	Jul 18, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/178
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Disclosed are methods and materials for assessing cardiac failure, cardiac hypertrophy, and left ventricular remodeling using microRNA levels. The level of microRNAs can be measured in a body fluid, such as plasma and serum.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.